Navigation Links
Alfacell Reports Financial Results for Third Quarter of Fiscal 2008
Date:6/9/2008

SOMERSET, N.J., June 9 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) today reported its financial results for the third quarter of fiscal 2008.

The company recorded a net loss of approximately $5.0 million, or $0.11 per basic and diluted common share, for the third fiscal quarter ended April 30, compared to a net loss of approximately $2.0 million, or $0.04 per basic and diluted common share, for the third quarter of fiscal 2007. Research and development expenses increased by approximately $1.4 million during the third quarter of fiscal 2008 as compared to the same quarter a year ago primarily due to expenses incurred related to the company's preparations for the completion of its ONCONASE(R) rolling New Drug Application ("NDA") submission. Increased general and administrative expenses of approximately $1.5 million for the third quarter of fiscal 2008 were primarily the result of the accrual of compensation expense related to entering a retirement agreement with the company's CEO in April 2008.

Net loss for the nine-month period ended April 30, 2008 of approximately $9.4 million, or $0.20 per basic and diluted common share, represents an increase of approximately $3.1 million, compared to the $6.3 million net loss, or $0.14 per basic and diluted common share, for the same period in fiscal 2007.

Cash and Liquidity

As of April 30, the company had cash and cash equivalents of approximately $7.8 million, a decrease of approximately $2.4 million, compared to cash and cash equivalents of approximately $10.2 million on Jan. 31. The company believes that this level of liquidity is sufficient to support its activities into the fourth quarter of fiscal year 2009, based on current expectations for the plan
'/>"/>

SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Alfacell Announces Retirement of Chief Executive Officer
2. Alfacell Reports Financial Results for Second Quarter of Fiscal 2008
3. Alfacell to Host Fiscal Second Quarter 2008 Financial Results Conference Call and Webcast
4. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
5. Alfacell to Host Webinar on RNA Interference-Like Mechanics of RNase Therapeutics on Nov. 29
6. Alfacell to Host Fiscal Fourth Quarter and Year-End 2007 Financial Results Conference Call and Webcast
7. Alfacell to Present at BIO InvestorForum 2007
8. YM BIOSCIENCES REPORTS NIMOTUZUMAB NSCLC CLINICAL DATA AT ASCO ANNUAL MEETING
9. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
10. Cord Blood America Reports CorCell, Its Major Acquisition in 2006, Turns Profitable
11. Bioheart, Inc. Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that the Company closed ... Oracle Investment Management, Jack W. Schuler , ... proceeds were $10.5 million, before offering expenses.  The ...
(Date:12/24/2014)... GMO corn cases filed across the United States, ... of being consolidated in a Kansas federal court for pretrial ... 162 Corn Litigation, MDL No. 2591 in the U.S. District ... Syngenta GMO corn multidistrict litigation (MDL) has been handed over ...
(Date:12/24/2014)... 23, 2014 On Friday, December 19, ... Omnibus and Continuing Resolution Appropriations Act of 2015, which ... to receive funding through the Congressionally Directed Medical Research ... The Hydrocephalus Association (HA), working in conjunction with its ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 Nashville Fertility Center ... treasurer for the American Society for Reproductive Medicine (ASRM), a ... reproductive medicine. In his new role as treasurer, Dr. ... will have a voice in furthering the mission of ASRM. ...
Breaking Biology Technology:Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3
... Bill of Rights are right about one thing: Wisconsin needs ... and local government. Our tax system hampers economic growth and ... ,But the opponents of TABOR are right about one thing, ... put at risk our economic growth and threaten our quality ...
... with the product managers at Palm and got a peek at ... be an entry-level digital organizer for the masses of people who ... simple product that delivered real value. After listening to the briefing ... close to the product marketing manager and said, "You're going to ...
... MobilePro Corp. announced today the company has ... , a Janesville-based Internet services provider. The deal is ... in annualized revenue and to be accretive to MobilePros ... of definitive agreements and customary closing conditions, is expected ...
Cached Biology Technology:Tax consumption over production to reform Wisconsins tax system 2Tax consumption over production to reform Wisconsins tax system 3The Palm to "de-Zire" 2The Palm to "de-Zire" 3
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) has ... Market 2015-2019" report to their offering. ... trend upcoming in this market is the increasing demand ... in recording of patient data for quick and correct ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... 2015-2019"  report to their offering. One ... technology. With continuous advances in technology, it is important ...
(Date:12/11/2014)... Dec. 10, 2014  Data Sciences International (DSI), the ... a new series of digital telemetry implants to ... M series, part of the PhysioTel™ Digital platform, ... possible physiologic data when incorporating functional endpoints into ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... 15th September, 2008: New research published today at the ... Mineral Research (ASBMR), Montral, Canada, reveals that less than ... claiming to take both calcium and vitamin D supplementation ... managing osteoporosis can be achieved with combination therapy of ...
... More than 30 years ago, Alfred Knudson Jr., M.D., ... that a person must lose both their paternal and ... called tumor-suppressor genes, in order to develop cancer. This ... globe in their quest for tumor suppressor genes. Now ...
... Ariz. Sept. 14, 2008 Investigators at the ... and less expensive way for scientists to find which ... unlike what shoppers find in grocery stores, TGen researchers ... 3-billion-base human genetic code, making it easier for scientists ...
Cached Biology News:Majority of osteoporosis patients not receiving calcium and vitamin D with treatment 2Majority of osteoporosis patients not receiving calcium and vitamin D with treatment 3'1-hit' event provides new opportunity for colon cancer prevention, say Fox Chase researchers 2TGen investigators devise faster, cheaper way of analyzing the human genome 2
... histochemically detect specific senescence ... in cultured cells and ... marker is only present ... found in presenescent/quiescent/immortal cells. ...
TAR DNA binding protein...
... Star strains are high-performance ... improved protein yield in ... (Figure 1). Because the ... mRNA more rapidly than ...
...
Biology Products: